Texas Senate Bill SB2003

Texas 2015 - 84th Regular

Caption

Relating to health benefit plan coverage for ovarian cancer screening.

Impact

The implementation of SB2003 will require insurance providers in Texas to include specific screenings, such as the CA 125 blood test and Pap smear tests, in their plans. This change is expected to increase early detection rates of ovarian and cervical cancers among women, potentially leading to improved survival rates and overall health outcomes. The bill emphasizes the need for adequate preventive care as an integral part of health insurance policies.

Summary

Senate Bill 2003 aims to enhance health coverage for women regarding the screening of ovarian cancer and cervical cancer. It mandates that health benefit plans must provide annual diagnostic examinations for early detection of these cancers for women aged 18 and older. This is a significant move towards improving women's health services and ensuring that necessary screenings are accessible under health insurance plans.

Contention

There may be concerns regarding the financial implications for insurance companies as they adjust their policies to comply with the new requirements. Critics might argue about the potential increase in insurance premiums as a result of expanded coverage, although proponents assert that the long-term benefits of early cancer detection outweigh these costs. Discussions around the bill likely involve balancing health care accessibility with the economic impact on insurance providers.